FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene

  • Mamata Singh
  • , Justin M. Leasure
  • , Christopher Chronowski
  • , Brian Geier
  • , Kathryn Bondra
  • , Wenrui Duan
  • , Lauren A. Hensley
  • , Miguel Villalona-Calero
  • , Ning Li
  • , Anthony M. Vergis
  • , Raushan T. Kurmasheva
  • , Changxian Shen
  • , Gary Woods
  • , Nikhil Sebastian
  • , Denise Fabian
  • , Rita Kaplon
  • , Sue Hammond
  • , Kamalakannan Palanichamy
  • , Arnab Chakravarti
  • , Peter J. Houghton

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology